David Wei, MD
Urology · Honolulu, HINPI 1184678401
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.7%), education and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 63.9% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $6,925 and has fallen 96.9% since, to $217 in 2025.
Across 60 payments — averaging $148.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- Boston Scientific$957
- Astellas Pharma US Inc$696
- Photocure Inc$367
- Johnson & Johnson$340
- Ferring Pharmaceuticals Inc.$230
- plus $627 from 6 others
What the payments were for
- Travel & lodging$1,92822%
- Food & beverage$3,98445%
- Education$3,00034%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 22 | $5,695 |
| Boston Scientific | 10 | $957 |
| Astellas Pharma US Inc | 11 | $696 |
| Photocure Inc | 2 | $367 |
| Johnson & Johnson(3 entities) | 4 | $340 |
| Ferring Pharmaceuticals Inc. | 2 | $230 |
| Neotract Inc. | 1 | $147 |
| Urogen Pharma, Inc. | 1 | $146 |
| Pfizer | 3 | $140 |
| Mallinckrodt Enterprises LLC | 1 | $118 |
| Angiodynamics, Inc. | 1 | $40 |
| Amgen | 2 | $37 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$5,250
- XTANDI$479
- Cysview$367
- GENERAL ERECTILE DYSFUNCTION$230
- AMS 800 Artificial Urinary Sphincter$153
- UroLift$147
- JELMYTO$146
- ADSTILADRIN$138
- SURGIFLO Hemostatic Matrix Family of Products$120
- EVICEL Fibrin Sealant (Human)$120
- OFIRMEV$118
- AMS$112
- SURGIFLO Hemostatic Matrix$111
- SURGICEL NU-KNIT$111
How this compares
$8,912 in reported general payments places this provider in the 85th percentile of 46 urology providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 331 | $5,061 |
| Finasteride | 225 | $3,091 |
| Trospium Chloride | 26 | $1,304 |
| Cephalexin | 95 | $727 |
| Ciprofloxacin Hcl | 77 | $519 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 61 | $507 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $127 |
Paid to pharmacies, not to this prescriber.
Other urology in Honolulu
- Sergei TikhonenkovHonolulu$22K
- Timur RoytmanHonolulu$22K
- Robert CarlileHonolulu$10K
- Charles KimHonolulu$9K
- Andrew SunHonolulu$9K
- Garry PeersHonolulu$8K
- Steve RiveraHonolulu$7K
- Tom FengHonolulu$6K
- Richard TsouHonolulu$5K
- Stephen ChinnHonolulu$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.